STSAX
Price
$7.20
Change
-$0.00 (-0.00%)
Updated
Dec 23 closing price
VIMAX
Price
$330.34
Change
-$1.55 (-0.47%)
Updated
Dec 23 closing price
Ad is loading...

STSAX vs VIMAX

Header iconSTSAX vs VIMAX Comparison
Open Charts STSAX vs VIMAXBanner chart's image
Allspring Common Stock C
Price$7.20
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$330.34
Change-$1.55 (-0.47%)
VolumeN/A
CapitalizationN/A
STSAX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
STSAX vs. VIMAX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STSAX is a Buy and VIMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. STSAX (755M). VIMAX pays higher dividends than STSAX: VIMAX (1.49) vs STSAX (0.00). STSAX was incepted earlier than VIMAX: STSAX (24 years) vs VIMAX (23 years). STSAX is a more actively managed with annual turnover of: 36.00 vs. VIMAX (13.00). STSAX has a lower initial minimum investment than VIMAX: STSAX (1000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.92 vs. STSAX (-7.10). VIMAX return over 5 years is better than : 52.16 vs. STSAX (-44.19).
STSAXVIMAXSTSAX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD-7.21615.379-47%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets755M190B0%
Annual Yield % from dividends0.001.49-
Returns for 1 year-7.1015.92-45%
Returns for 3 years-40.156.98-575%
Returns for 5 years-44.1952.16-85%
Returns for 10 years-62.17118.50-52%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQN4.480.09
+2.05%
Algonquin Power & Utilities Corp
XYL117.510.37
+0.32%
Xylem
DRUG38.690.04
+0.10%
Bright Minds Biosciences
ARDX4.58-0.24
-4.98%
Ardelyx
GDTC2.37-0.19
-7.42%
CytoMed Therapeutics Limited